FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.
Comments
0
Be the first to comment
Sign up now and become a member of the 5-Minute Pharma Daily community!
Comments
0Be the first to comment
Sign up now and become a member of the 5-Minute Pharma Daily community!